Symbols

NUTX

Nutex Health·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

NUTX fundamentals

NUTX Q2 2025 Earnings

Nutex Health (NUTX) released its earnings on Aug 14, 2025: revenue was 243.99M (YoY +220.69%), beat estimates; EPS was -2.95 (YoY -4114.29%), beat estimates.

Revenue / YoY

243.99M

+220.69%

EPS / YoY

-2.95

-4114.29%

Report date

Aug 14, 2025

NUTX Earnings Call Summary for Q2,2025

Revenue explosion: Q2 2025 revenue up 220% YoY to $244M, driven by 350% growth in Hospital Division. Gross margin 51.1% vs. 29.7% YoY.
Arbitration success: 85% win rate in federal arbitration, 75%+ collection rate. $167.7M arbitration revenue (71% of Hospital Division).
Buyback & growth: $25M stock buyback announced; 15 new hospitals in pipeline, 2 opening Q4 2025.
Financial strength: $96.7M cash, 442% YoY operating cash flow growth. Noncash accounting adjustments with no cash impact.
Defensive move: Rebutted short seller claims, emphasizing regulatory compliance and industry-wide arbitration trends.

Earnings

EPS

Revenue

Revenue & Expenses

NUTX has released its 2025 Q3 earnings report, with revenue of 267.80M, reflecting a YoY change of 239.87%, and net profit of 96.80M, showing a YoY change of 1451.00%. The Sankey diagram below clearly presents NUTX's revenue sources and cost distribution.

Key Indicators

Nutex Health (NUTX) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Nutex Health (NUTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Nutex Health (NUTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Nutex Health (NUTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown